William T. Budd, Ph.D. - Publications

Affiliations: 
2012 Integrative Life Sciences Virginia Commonwealth University, Richmond, VA, United States 
Area:
Cell Biology, Bioinformatics Biology, System Science Engineering, Oncology

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Seashols-Williams SJ, Budd W, Clark GC, Wu Q, Daniel R, Dragoescu E, Zehner ZE. miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis. Plos One. 11: e0159601. PMID 27447934 DOI: 10.1371/Journal.Pone.0159601  0.748
2015 Budd WT, Seashols-Williams SJ, Clark GC, Weaver D, Calvert V, Petricoin E, Dragoescu EA, O'Hanlon K, Zehner ZE. Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis. Plos One. 10: e0142373. PMID 26544868 DOI: 10.1371/Journal.Pone.0142373  0.716
2013 Budd WT, Seashols S, Weaver D, Joseph C, Zehner ZE. A networks method for ranking microRNA dysregulation in cancer. Bmc Systems Biology. 7: S3. PMID 24564923 DOI: 10.1186/1752-0509-7-S5-S3  0.512
2012 Budd WT, Weaver DE, Anderson J, Zehner ZE. microRNA dysregulation in prostate cancer: network analysis reveals preferential regulation of highly connected nodes. Chemistry & Biodiversity. 9: 857-67. PMID 22589088 DOI: 10.1002/Cbdv.201100386  0.745
2012 Budd WT, Weaver DE, Calvert V, Petricoin EF, Ware JL, Zehner ZE. Abstract B54: miR-125b and miR-17-3p: Newly identified tumor suppressors for prostate cancer Cancer Research. 72: B54-B54. DOI: 10.1158/1538-7445.Prca2012-B54  0.738
2009 Zhang X, Ladd A, Dragoescu E, Budd WT, Ware JL, Zehner ZE. MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection. Clinical & Experimental Metastasis. 26: 965-79. PMID 19771525 DOI: 10.1007/S10585-009-9287-2  0.702
Show low-probability matches.